“Why Growing Retractions Are (Mostly) a Good Sign”: New study makes the case

Daniele Fanelli
Daniele Fanelli

Retraction Watch readers will no doubt be familiar with the fact that retraction rates are rising, but one of the unanswered questions has been whether that increase is due to more misconduct, greater awareness, or some combination of the two.

In a new paper in PLOS Medicine, Daniele Fanelli, who has studied misconduct and related issues, tries to sift through the evidence. Noting that the number of corrections has stayed constant since 1980, Fanelli writes that: Continue reading “Why Growing Retractions Are (Mostly) a Good Sign”: New study makes the case

Cancer-anorexia paper retracted for “unacceptable” duplication

doveDrug Design, Development and Therapy has retracted a 2013 paper by a group from Italy for duplication.

The retraction notice for the paper, “Drugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome,” fairly bristles with indignation: Continue reading Cancer-anorexia paper retracted for “unacceptable” duplication

Melendez notches retraction 14, Lemus now stands at 12

int j biochem mol bioTwo researchers who have appeared frequently on Retraction Watch have racked up another retraction each.

This is the fourteenth retraction for Alirio Melendez, who was found guilty of misconduct by the National University of Singapore but denies the allegations. Here’s the notice in The International Journal of Biochemistry & Cell Biology for “Environmental toxicogenomics: A post-genomic approach to analysing biological responses to environmental toxins,” a paper published in Environmental Research and cited nine times, according to Thomson Scientific’s Web of Knowledge: Continue reading Melendez notches retraction 14, Lemus now stands at 12

Drug withdrawal: St. Louis Krokodil paper disappears

ajmedOn November 11, St. Louis’s KTVI reported that krokodil, a nasty opioid concoction with roots in Russia, had arrived in their town. They based that report on a case study published in the American Journal of Medicine, “Krokodil’—A Designer Drug From Across the Atlantic, with Serious Consequences,” and interviewed two of the paper’s authors, Dany Thekkemuriyil and Unnikrishnan Pillai.

The case study involved a 30-year-old man the Thekkemuriyil and Pillai said they had seen at St. Mary’s Health Center in Richmond Heights, Missouri. As the St. Louis Post-Dispatch reported a few days later: Continue reading Drug withdrawal: St. Louis Krokodil paper disappears

Mathematicians have second paper retracted

inequalA group of mathematicians in Iran have had a second paper retracted, and if we may, neither of the notices adds up.

Here’s the notice: for the new paper, in the Journal of Inequalities and Applications: Continue reading Mathematicians have second paper retracted

Lack of ethical clearance prompts expression of concern from bone journal

jbjsThe Journal of Bone and Joint Surgery has issued an expression of concern about a paper whose authors may not have obtained proper ethical clearance.

Here’s the notice, signed by editor in chief Vernon Tolo: Continue reading Lack of ethical clearance prompts expression of concern from bone journal

Weekend reads: China’s scientific publishing black market, how to blow the whistle, and more

booksIt’s been a busy week here at Retraction Watch, with breaking news about hotly debated papers from Nature and about GMOs, but there have been interesting stories about retractions and scientific misconduct elsewhere, too. Here’s a sampling:
Continue reading Weekend reads: China’s scientific publishing black market, how to blow the whistle, and more

P values: Scientific journals’ top ten plagiarism euphemisms

labtimes1113The other day, we nominated a phrase in a retraction notice for the prize “of most-extra-syllables-used-to-say-the-word-plagiarism” because a journal decided to call the act “inclusion of significant passages of unattributed material from other authors.”

That lovely phrase can now be added to our list of best euphemisms for plagiarism, which we highlight in our most recent column for LabTimes. There, you’ll find such gems as “unattributed overlap,” “a significant originality issue,” an “approach,” and an “administrative error.”

As we write: Continue reading P values: Scientific journals’ top ten plagiarism euphemisms

Controversial Seralini GMO-rats paper to be retracted

food and chemical toxicologyA heavily criticized study of the effects of genetically modified maize and the Roundup herbicide on rats is being retracted — one way or another.

The paper — by Gilles Seralini and colleagues — was published in Food and Chemical Toxicology last year. There have been calls for retraction since then, along with other criticism and a lengthy exchange of letters in the journal. Meanwhile, the paper has been cited 28 times, according to Thomson Scientific’s Web of Knowledge, and the French National Assembly (their lower house of Parliament) held a long hearing on the paper last year, with Seralini and other scientists testifying.

Now, as reported in the French media, the editor of the journal, A. Wallace Hayes, has sent Seralini a letter saying that the paper will be retracted if Seralini does not agree to withdraw it.

Here’s most of the November 19 letter, including Hayes’ proposed retraction notice: Continue reading Controversial Seralini GMO-rats paper to be retracted

At long last, disputed dance study retracted from Nature

trivers natureA 2005 Nature study that has vexed one of its authors since 2007 is finally being retracted.

The notice for “Dance reveals symmetry especially in young men,” by William M. Brown, Lee Cronk, Keith Grochow, Amy Jacobson, C. Karen Liu, Zoran Popovic´& Robert Trivers, says very little: Continue reading At long last, disputed dance study retracted from Nature